Stefan Cano, Modus Outcomes’ Chief Scientific Officer and co-developer of the Q-Protfolio is not sitting still! Stefan co-authored a paper describing  the development and use the FACE-Q Head and Neck Cancer Module in clinical research at Memorial Sloan Kettering Cancer Center, New York. The goal of the paper was to provide initial evidence to support the FACE-Q Head and Neck Cancer Module to provide data from the patient’s perspective for de-escalation trials, novel therapeutic agent trials, and the development of new surgical techniques.

If you are interested in learning more about the FACE-Q Head and Neck Module or the Q-Portfolio, please visit or contact Andrea Murison to schedule a call or a training session with our experts.